Nathan D. Jorgensen's Net Worth
$511 Thousand
Who is Nathan D. Jorgensen?
Nathan D. Jorgensen does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Vor Biopharma Inc..
SEC CIK
Nathan D. Jorgensen's CIK is 0001842523
Past Insider Trading and Trends
2022 was Nathan D. Jorgensen's most active year for acquiring shares with 3 total transactions. Nathan D. Jorgensen's most active month to acquire stocks was the month of January. 2023 was Nathan D. Jorgensen's most active year for disposing of shares, totalling 5 transactions. Nathan D. Jorgensen's most active month to dispose stocks was the month of January. 2022 saw Nathan D. Jorgensen paying a total of $0.00 for 307,000 shares, this is the most they've acquired in one year. In 2023 Nathan D. Jorgensen cashed out on 15,122 shares for a total of $58,813.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vor Biopharma Inc. (VOR) Snapshot price: $2.28
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.44% | -834.00 |
$1.75 | -$1,459.50 | 189.4K |
May 6
| |||
Form 4
| -0.48% | -917.00 |
$1.77 | -$1,623.09 | 190.24K |
May 1
| |||
Form 4
| -3.20% | -6.31K |
$2.27 | -$14,323.70 | 191.15K |
Mar 1
| |||
Form 4
| -0.50% | -985.00 |
$2.32 | -$2,285.20 | 197.46K |
Feb 6
| |||
Form 4
| +33.68% | 50K |
—
|
—
| 198.45K |
Jan 29
| |||
Form 4
| -0.57% | -834.00 |
$1.82 | -$1,517.88 | 145.65K |
Nov 6
| |||
Form 4
| -4.13% | -6.31K |
$2.67 | -$16,847.70 | 146.48K |
Sep 1
| |||
Form 4
| -0.54% | -834.00 |
$2.67 | -$2,226.78 | 152.79K |
Aug 7
| |||
Form 4
| -0.54% | -834.00 |
$4.14 | -$3,452.76 | 153.63K |
May 8
| |||
Form 4
| -3.92% | -6.31K |
$5.51 | -$34,768.10 | 154.46K |
Mar 1
| |||
Form 4
| +39.47% | 45.5K |
—
|
—
| 160.77K |
Feb 6
| |||
Form 4
| +293.83% | 86K |
—
|
—
| 115.27K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +13.73% | 3.53K |
—
|
—
| 29.27K |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Voyager Therapeutics, Inc. (VYGR) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||